Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Combination of temsirolimus (CCI-779) with chemoradiation in newly diagnosed glioblastoma multiforme (GBM) (NCCTG trial N027D) is associated with increased infectious risks.

Authors
Type
Published Article
Journal
Clinical Cancer Research
1078-0432
Publisher
American Association for Cancer Research (AACR)
Publication Date
Volume
16
Issue
22
Pages
5573–5580
Identifiers
DOI: 10.1158/1078-0432.CCR-10-1453
PMID: 20921209
Source
Medline

Abstract

Statistics

Seen <100 times